Business Context and Reporting Period
Company: Herbalife Ltd.
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2024
Business Overview: Herbalife is a global nutrition company operating in 95 markets, selling weight management, targeted nutrition, sports nutrition, and outer nutrition products through a direct-selling network of independent Members. The company reported approximately 6.2 million total Members as of year-end 2024.
Key Financial Metrics
| Metric | 2024 | 2023 | Change |
|---|---|---|---|
| Net Sales | $4,993.1 million | $5,062.4 million | (1.4%) |
| Gross Profit | $3,888.8 million | $3,871.4 million | 0.4% |
| Gross Margin | 77.9% | 76.5% | +140 bps |
| Operating Income | $385.9 million | $356.4 million | 8.3% |
| Net Income | $254.3 million | $142.2 million | 78.8% |
| Diluted EPS | $2.50 | $1.42 | 76.1% |
| Operating Cash Flow | $285.4 million | $357.5 million | (20.2%) |
| Cash and Equivalents | $415.3 million | $575.2 million | (27.8%) |
| Total Debt (Carrying Value) | $2,260.1 million | $2,562.4 million | (11.8%) |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 1.4% primarily due to a 4.0% decline in Volume Points (sales volume) and a 2.6% unfavorable foreign currency impact, partially offset by a 5.3% favorable price increase impact.
- Profitability Surge: Net income increased 78.8% despite lower sales. This was driven by a $145.7 million reduction in income taxes due to a corporate reorganization in Q4 2024, which generated a $147.3 million deferred tax benefit.
- Regional Performance:
- North America: Sales down 6.8% (Volume down 11.3%).
- China: Sales down 9.1% (Volume down 6.5%) due to economic difficulties.
- Latin America: Sales up 1.4% (Volume flat) driven by price increases.
- Asia Pacific (ex-China): Sales up 0.6% (Volume flat).
- Debt Refinancing: In April 2024, the company refinanced its credit facility and issued $800 million in 12.25% Senior Secured Notes due 2029. This increased the weighted-average interest rate on borrowings to 10.35% from 7.62% in 2023.
Guidance, Outlook, and Risks
- Restructuring and Transformation: The company completed a "Transformation Program" (substantially complete as of Dec 31, 2024) and a "Restructuring Program" (substantially complete as of Dec 31, 2024). These initiatives incurred $69.1 million and $13.3 million in expenses respectively in 2024, with expected annual savings of $80 million and $110 million.
- Digital Investment: The company is investing in a multi-year "Digital Technology Program" (Herbalife One) to rebuild member-facing tools. Approximately $330 million has been incurred to date, with $26.7 million in expenses recognized in 2024.
- Key Risks:
- Regulatory: Ongoing compliance with the 2016 FTC Consent Order, which restricts U.S. distributor compensation and marketing practices.
- Geopolitical: Exposure to inflation, foreign exchange fluctuations, and conflicts in Ukraine and the Middle East.
- China Operations: Unique regulatory environment requiring a modified business model; recent economic slowdown impacting volume.
- Debt Covenants: The 2024 Credit Facility requires maintaining a maximum total leverage ratio of 4.50:1.00 (stepping down to 4.00:1.00 by Sept 2025).
Investor Verification Checklist
- Tax Benefit Sustainability: Verify the permanence of the $147.3 million deferred tax benefit from the Q4 2024 corporate reorganization and the associated valuation allowance assumptions.
- Volume Trends: Monitor Volume Points trends, particularly in North America and China, as these are leading indicators of future revenue given the recent 4.0% global decline.
- Debt Service Capacity: Assess the impact of the higher interest rate (10.35%) on future cash flows and the ability to meet the 4.50:1.00 leverage covenant.
- China Regulatory Status: Review updates on the direct-selling license renewal in Vietnam (renewed Jan 2025) and ongoing regulatory scrutiny in China.
- Member Retention: Track sales leader retention rates (70.3% for 2025 re-qualification) as a proxy for network stability.